Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group - PubMed (original) (raw)
Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group
D A Pegues et al. J Pediatr. 1994 May.
Abstract
To assess the risk of acquisition of Pseudomonas cepacia by person-to-person transmission at cystic fibrosis summer camps, we conducted in 1990 a study at three camps attended by patients with cystic fibrosis who had P. cepacia infection and patients without P. cepacia infection but who were considered susceptible to infection. We obtained sputum or throat cultures from campers on their arrival at, weekly during, at the end of, and 14 to 30 days after camp. We compared the incidence of sputum conversion of patients at camp with that of patients outside camp by culturing specimens from noncamper control subjects with cystic fibrosis who were known not to be infected < or = 2 weeks before and 4 to 6 weeks after camp. We also determined the risk factors for P. cepacia acquisition by determining the relative risk of acquisition between campers who were exposed versus campers who were not exposed to campers known to be infected or to potential environmental sources of P. cepacia at camp. The ribotype of P. cepacia isolates from campers with sputum conversion was compared with that of isolates from other campers and from an environmental source. The cumulative incidence of sputum conversion during the study period was 6.1% (11/181) among campers compared with no incidence (0/92) among noncampers (p = 0.02, Fisher Exact Test). The incidence of sputum conversion at camp varied according to the prevalence of campers with known infection (p < 0.001, chi-square test for trend). The rate of sputum conversion was higher in the camp with longer duration (relative risk = 12.0; 95% confidence interval = 2.7 to 53.5). Ribotyping showed that P. cepacia isolates from all 11 campers with sputum conversion were identical or similar (1 to 2 band difference) to isolates of other P. cepacia-infected campers including co-converters. These results suggest that P. cepacia can be acquired by patients with cystic fibrosis who are attending summer camp for such patients, possibly through person-to-person transmission, and that the risk increases with the prevalence of P. cepacia-infected campers and the duration of camp.
Similar articles
- Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.
Steinbach S, Sun L, Jiang RZ, Flume P, Gilligan P, Egan TM, Goldstein R. Steinbach S, et al. N Engl J Med. 1994 Oct 13;331(15):981-7. doi: 10.1056/NEJM199410133311504. N Engl J Med. 1994. PMID: 7521938 - Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.
Govan JR, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, Greening AP, Webb AK. Govan JR, et al. Lancet. 1993 Jul 3;342(8862):15-9. doi: 10.1016/0140-6736(93)91881-l. Lancet. 1993. PMID: 7686239 - Pseudomonas cepacia pulmonary infection in adults with cystic fibrosis: is nosocomial acquisition occurring?
Taylor RF, Dalla Costa L, Kaufmann ME, Pitt TL, Hodson ME. Taylor RF, et al. J Hosp Infect. 1992 Jul;21(3):199-204. doi: 10.1016/0195-6701(92)90076-x. J Hosp Infect. 1992. PMID: 1379274 - The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.
Tablan OC, Martone WJ, Jarvis WR. Tablan OC, et al. Eur J Epidemiol. 1987 Dec;3(4):336-42. doi: 10.1007/BF00145642. Eur J Epidemiol. 1987. PMID: 3319668 Review. - Training oncology camp volunteers. A developmental and strengths approach.
Beder J. Beder J. Cancer Pract. 2000 May-Jun;8(3):129-34. doi: 10.1046/j.1523-5394.2000.83006.x. Cancer Pract. 2000. PMID: 11898137 Review.
Cited by
- Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.
Campana S, Taccetti G, Ravenni N, Favari F, Cariani L, Sciacca A, Savoia D, Collura A, Fiscarelli E, De Intinis G, Busetti M, Cipolloni A, d'Aprile A, Provenzano E, Collebrusco I, Frontini P, Stassi G, Trancassini M, Tovagliari D, Lavitola A, Doherty CJ, Coenye T, Govan JR, Vandamme P. Campana S, et al. J Clin Microbiol. 2005 Oct;43(10):5136-42. doi: 10.1128/JCM.43.10.5136-5142.2005. J Clin Microbiol. 2005. PMID: 16207975 Free PMC article. - Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia.
Jacques I, Derelle J, Weber M, Vidailhet M. Jacques I, et al. Eur J Pediatr. 1998 May;157(5):427-31. doi: 10.1007/s004310050844. Eur J Pediatr. 1998. PMID: 9625343 - Distribution of quorum-sensing genes in the Burkholderia cepacia complex.
Lutter E, Lewenza S, Dennis JJ, Visser MB, Sokol PA. Lutter E, et al. Infect Immun. 2001 Jul;69(7):4661-6. doi: 10.1128/IAI.69.7.4661-4666.2001. Infect Immun. 2001. PMID: 11402012 Free PMC article. - Clinical significance of microbial infection and adaptation in cystic fibrosis.
Hauser AR, Jain M, Bar-Meir M, McColley SA. Hauser AR, et al. Clin Microbiol Rev. 2011 Jan;24(1):29-70. doi: 10.1128/CMR.00036-10. Clin Microbiol Rev. 2011. PMID: 21233507 Free PMC article. Review. - Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.
Kamal F, Dennis JJ. Kamal F, et al. Appl Environ Microbiol. 2015 Feb;81(3):1132-8. doi: 10.1128/AEM.02850-14. Epub 2014 Dec 1. Appl Environ Microbiol. 2015. PMID: 25452284 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical